✦ LIBER ✦

EGRF-CD533 acts as a PAN-ERBB receptor tyrosine kinase inhibitor

✍ Scribed by J.N Contessa; A Abell; G Lammering; T Hewit; K Valerie; R.K Schmidt-Ullrich

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuregulin-4: a novel growth factor that

✍ Harari, D; Tzahar, E; Romano, J; Shelly, M; Pierce, J H; Andrews, G C; Yarden, Y 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 231 KB

A randomized, phase II, dose-finding stu

✍ Olivier Rixe; Sandra X. Franco; Denise A. Yardley; Stephen R. Johnston; Miguel M 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 367 KB

ChemInform Abstract: Rational Design of

✍ Li Sun; Jean Cui; Congxin Liang; Yong Zhou; Asaad Nematalla; Xueyan Wang; Hui Ch 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 2 views